Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 11/20 | 0.62 |
| ▸ | OPRK1 | P41145 | 11/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 10/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.48 |
| ▸ | MRGPRX2 | Q96LB1 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20170866 | 0.84 | OPRM1 (0.57) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL20170856 | 0.83 | OPRM1 (0.61) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL20170733 | 0.83 | OPRM1 (0.61) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL20170737 | 0.83 | OPRM1 (0.61) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL20170773 | 0.81 | OPRM1 (0.66) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL20170648 | 0.78 | OPRM1 (0.62) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL12948089 | 0.77 | OPRM1 (1.00) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL13100920 | 0.76 | OPRM1 (0.81) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL13534483 | 0.76 | OPRM1 (0.81) | OPRM1OPRK1OPRD1LMNAPDE4D | |
| SCHEMBL14852885 | 0.76 | OPRM1 (0.81) | OPRM1OPRK1OPRD1LMNAPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2453895-B1 | (+) - MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF | MALLINCKRODT LLC (US) | 2018-05-23 | — | — | EP | disclosed |